Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Bio Capital Impact Fund (BCIF) is a venture capital firm based in Melbourne, Australia, established in 2016. The fund focuses on investing in innovative and disruptive technologies within the biotech sector, targeting medical, agricultural, and industrial applications. BCIF operates as an evergreen, open-ended fund, which allows for continuous deal flow and ongoing capital support for its investments. This structure enables the firm to adapt to changing market conditions and invest in high-potential opportunities as they arise.
As of now, BCIF has positioned itself as a key player in the global biotech investment landscape, with a focus on high-growth, later-stage investments. The firm is geography-agnostic, investing in diversified international markets, particularly in Oceania. BCIF's management structure is designed to align with investors' interests, ensuring tax-effective arrangements that benefit both the fund and its limited partners.
BCIF invests in several key themes within the healthcare sector, which they refer to as 'waves.' These include personalized/precision medicine, infectious diseases and drug resistance, healthspan, and feeding the world. The fund targets high-growth, later-stage investments across diversified international markets, focusing on sectors such as biotech, healthcare, and agtech.
In personalized/precision medicine, BCIF seeks investments in targeted therapies, next-generation sequencing, and gene editing technologies. The infectious diseases and drug resistance wave focuses on developing novel vaccines, antibacterial solutions, and rapid diagnostic tests. Healthspan investments aim to improve longevity and quality of life through wellness and preventative medicine. Lastly, the feeding the world theme supports agricultural innovations that enhance food security and sustainability.
Helen Fisher - Managing Director and CEO. Helen has extensive experience in venture capital and has led numerous successful investments in the biotech sector.
Julian Chick - Public Portfolio Manager. Julian specializes in managing public investments and has a strong background in financial analysis.
Peter Smith - Investment Manager - Private Investments. Peter focuses on private equity investments and has a track record of identifying high-potential startups.
Jeremy Blimbaum - Head of Operations - Europe. Jeremy oversees BCIF's operations in Europe, ensuring smooth execution of investment strategies.
Robert Scott - Principal - China. Robert manages BCIF's investments in China, leveraging his expertise in the Asian market.
Brian Patterson - Risk and Compliance Director. Brian ensures that BCIF adheres to regulatory requirements and manages risk across the portfolio.
Curtis Scribner - Medical and Regulatory Affairs Director. Curtis provides insights on regulatory matters and medical affairs related to portfolio companies.
Gavin Houghton - Chair, Investment Committee. Gavin leads the investment committee, guiding BCIF's investment decisions.
Andrew Wilks - Member, Investment Committee. Andrew contributes to investment evaluations and decision-making processes.
Bob Moses - Member, Investment Committee. Bob brings extensive experience in venture capital to the committee.
Olga Kubassova - Member, Investment Committee. Olga provides insights on market trends and investment opportunities.
Gerhard Vorster - Chair, Advisory Board. Gerhard advises BCIF on strategic initiatives and market positioning.
Andrew Tyndale - Member, Advisory Board. Andrew offers guidance on investment strategies and portfolio management.
Zarmeen Pavri - Member, Advisory Board. Zarmeen provides insights on industry trends and potential investment opportunities.
Marjorie Kaufman - Member, Advisory Board. Marjorie advises on regulatory and compliance matters affecting the portfolio.
To pitch Bio Capital Impact Fund, founders should use the contact form available on their website. A well-prepared pitch deck should include details about the startup's business model, market opportunity, and alignment with BCIF's investment themes. A warm introduction is preferred, and founders can expect a response within a reasonable timeframe after submission.
What are Bio Capital Impact Fund's investment criteria?
BCIF focuses on high-growth, later-stage investments in the biotech sector, particularly in healthcare themes such as personalized medicine, infectious diseases, healthspan, and agricultural innovations. The fund targets Series A to Series D and growth equity stages.
How can I pitch to Bio Capital Impact Fund?
Founders interested in pitching to BCIF should prepare a detailed presentation that outlines their business model, market opportunity, and how their technology aligns with BCIF's investment themes. A warm introduction is preferred, and interested parties can reach out through the contact form on their website.
What makes Bio Capital Impact Fund different from other investors?
BCIF operates as an evergreen fund, allowing for continuous capital deployment without a sunset date. This structure enables them to support their portfolio companies over the long term and adapt to changing market conditions.
What is the geographic scope of Bio Capital Impact Fund's investments?
BCIF is geography-agnostic and invests in diversified international markets, with a particular focus on Oceania. This global approach allows them to tap into various biotech innovations worldwide.
What kind of post-investment involvement does Bio Capital Impact Fund have?
BCIF typically engages with its portfolio companies through board involvement and operational support, ensuring alignment with their strategic goals and providing resources to help them scale effectively.
What is the typical check size for investments made by Bio Capital Impact Fund?
While specific check sizes are not disclosed, BCIF targets investments across Series A to Series D and growth equity stages, indicating a flexible approach to funding based on the needs of the startup.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.